195 related articles for article (PubMed ID: 21537867)
1. Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.
van der Ploeg AP; van Akkooi AC; Schmitz PI; van Geel AN; de Wilt JH; Eggermont AM; Verhoef C
Ann Surg Oncol; 2011 Nov; 18(12):3300-8. PubMed ID: 21537867
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Positive Deep Pelvic Nodal Involvement in Patients with Palpable Groin Melanoma Metastases: Can the Extent of Surgery be Safely Minimized? : A Retrospective, Multicenter Cohort Study.
Oude Ophuis CM; van Akkooi AC; Hoekstra HJ; Bonenkamp JJ; van Wissen J; Niebling MG; de Wilt JH; van der Hiel B; van de Wiel B; Koljenović S; Grünhagen DJ; Verhoef C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1172-80. PubMed ID: 26014150
[TBL] [Abstract][Full Text] [Related]
3. Regional control and morbidity after superficial groin dissection in melanoma.
Shada AL; Slingluff CL
Ann Surg Oncol; 2011 May; 18(5):1453-9. PubMed ID: 21136182
[TBL] [Abstract][Full Text] [Related]
4. Deep lymph node metastases in the groin significantly affects prognosis, particularly in sentinel node-positive melanoma patients.
Niebling MG; Wevers KP; Suurmeijer AJ; van Ginkel RJ; Hoekstra HJ
Ann Surg Oncol; 2015 Jan; 22(1):279-86. PubMed ID: 25008028
[TBL] [Abstract][Full Text] [Related]
5. Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.
Mozzillo N; Caracò C; Marone U; Di Monta G; Crispo A; Botti G; Montella M; Ascierto PA
World J Surg Oncol; 2013 Feb; 11():36. PubMed ID: 23379355
[TBL] [Abstract][Full Text] [Related]
6. The Diagnostic Value of PET/CT Imaging in Melanoma Groin Metastases.
van Wissen J; van der Hiel B; van der Hage JA; van de Wiel BA; Wouters MW; van Akkooi AC
Ann Surg Oncol; 2016 Jul; 23(7):2323-9. PubMed ID: 26920386
[TBL] [Abstract][Full Text] [Related]
7. Tumor-positive sentinel node biopsy of the groin in clinically node-negative melanoma patients: superficial or superficial and deep lymph node dissection?
van der Ploeg IM; Valdés Olmos RA; Kroon BB; Nieweg OE
Ann Surg Oncol; 2008 May; 15(5):1485-91. PubMed ID: 18324444
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic lymph node dissection in melanoma: different prognosis for different macrometastasis sites?
Wevers KP; Bastiaannet E; Poos HP; van Ginkel RJ; Plukker JT; Hoekstra HJ
Ann Surg Oncol; 2012 Nov; 19(12):3913-8. PubMed ID: 22588472
[TBL] [Abstract][Full Text] [Related]
10. Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin--an analysis of survival and local recurrence.
Kretschmer L; Neumann C; Preusser KP; Marsch WC
Acta Oncol; 2001; 40(1):72-8. PubMed ID: 11321665
[TBL] [Abstract][Full Text] [Related]
11. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.
Allan CP; Hayes AJ; Thomas JM
ANZ J Surg; 2008 Nov; 78(11):982-6. PubMed ID: 18959697
[TBL] [Abstract][Full Text] [Related]
12. Is superficial inguinal node dissection adequate for regional control of malignant melanoma in patients with N1 disease?
Smith OJ; Rimouche S; Oudit D; Mowatt D; Ross GL
J Plast Reconstr Aesthet Surg; 2013 Apr; 66(4):472-7. PubMed ID: 23391539
[TBL] [Abstract][Full Text] [Related]
13. Pelvic lymph node dissection in metastatic melanoma to the groin should not be abandoned yet.
Faut M; Kruijff S; Hoekstra HJ; van Ginkel RJ; Been LB; van Leeuwen BL
Eur J Surg Oncol; 2018 Nov; 44(11):1779-1785. PubMed ID: 30054111
[TBL] [Abstract][Full Text] [Related]
14. Combined clearance of pelvic and superficial nodes for clinical groin melanoma.
West CA; Saleh DB; Peach H
J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1711-8. PubMed ID: 25219338
[TBL] [Abstract][Full Text] [Related]
15. Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population.
Spillane AJ; Haydu L; McMillan W; Stretch JR; Thompson JF
Ann Surg Oncol; 2011 Sep; 18(9):2521-8. PubMed ID: 21556951
[TBL] [Abstract][Full Text] [Related]
16. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
[TBL] [Abstract][Full Text] [Related]
17. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
Hughes TM; A'Hern RP; Thomas JM
Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
[TBL] [Abstract][Full Text] [Related]
18. Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma.
Egger ME; Brown RE; Roach BA; Quillo AR; Martin RC; Scoggins CR; Stromberg AJ; McMasters KM
J Am Coll Surg; 2014 Jul; 219(1):101-8. PubMed ID: 24726566
[TBL] [Abstract][Full Text] [Related]
19. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
Tas F; Erturk K
Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
[TBL] [Abstract][Full Text] [Related]
20. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
